Symbol
| PFN1
| contributors: mct/pgu - updated : 19-06-2013
|
HGNC name
| profilin 1
|
HGNC id
| 8881
|
corresponding disease(s)
|
ALS18
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
sensitizes cancer cells to apoptosis through the typical intrinsic apoptotic pathway | constitutional
|  
|  
| --over
|  
|
reduces the aggregation of polyglutamine-expanded HTT and androgen receptor (AR) peptides | |
Susceptibility
|
to Amyotrophic lateral sclerosis (ALS18) |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| has the potential to serve as a diagnostic or progression biomarker in renal cell carcinoma | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | urinary | | |
therapeutic target in renal cell carcinoma |
| | |
| homozygous Col2pfn1 mice develop progressive chondrodysplasia caused by disorganization of the growth plate and defective chondrocyte cytokinesis, indicated by the appearance of binucleated cells | |
Pfn1-deficient mice exhibited an absence of trabecular bone in the marrow space of appendicular long bone 1) |